Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
02/2003
02/20/2003WO2003014101A1 Hydroxamic acid derivatives
02/20/2003WO2003014094A2 Heterocyclic aryl sulphonamides
02/20/2003WO2003014090A1 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
02/20/2003WO2003014082A1 Cyclopenta ` b ! indole derivatives as spla2 inhibitors
02/20/2003WO2003014078A2 Muc7d1 peptides as antifungal and antibacterial agents
02/20/2003WO2003013606A1 Thrombomodulin-containing medicinal compositions
02/20/2003WO2003013601A1 Toxin associated with sudden infant death syndrome, and uses thereof
02/20/2003WO2003013600A1 Vaccine composition comprising at least two valences, one enhanced with adjuvant and not the other
02/20/2003WO2003013596A1 Vaccine
02/20/2003WO2003013593A2 Composite superimmunogen for bi-functional vaccine use for the treatment of illnesses associated with a stromal tissue disorder
02/20/2003WO2003013572A1 Treatment of tuberculosis using immunomodulator compounds
02/20/2003WO2003013571A1 Peptidomimetics of biologically active metallopeptides
02/20/2003WO2003013550A1 Micronutrient phosphates as dietary and health supplements
02/20/2003WO2003013545A1 Novel benzo-fused heterocycles as endothelin antagonisits
02/20/2003WO2003013530A2 Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid derivatives as nmda antagonists
02/20/2003WO2003013523A1 Sh3 protein domains and their ligands
02/20/2003WO2003013517A1 Aminoisoxazole derivatives active as kinase inhibitors
02/20/2003WO2003013513A1 Stable emulsion composition
02/20/2003WO2003013493A1 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs
02/20/2003WO2003013489A1 Treatment of nail infections with no
02/20/2003WO2003013475A1 Injectable foam and novel pharmaceutical applications thereof
02/20/2003WO2003013440A2 Treatment and prevention of heat shock protein-associated diseases and conditions
02/20/2003WO2003013434A2 Methods and compositions for treating diseases associated with excesses in ace
02/20/2003WO2003013432A2 Methods of use for novel sulfur containing organic nitrate compounds
02/20/2003WO2003013428A2 Nutritional supplements and methods of using same
02/20/2003WO2003013425A2 In vitro assays for inhibitors of hiv capsid conformational changes and for hiv capsid formation
02/20/2003WO2003013424A2 Use of r-nsaid compounds for anti-hiv treatment
02/20/2003WO2002098360A3 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
02/20/2003WO2002094874A3 Internalisation of virus into cells
02/20/2003WO2002083733A3 Polynucleotides and polypeptides of the ifnalpha-6 gene
02/20/2003WO2002081621A3 Vaccine against the nile fever virus
02/20/2003WO2002080668A3 Antimicrobial formulations
02/20/2003WO2002079464A3 Viral vectors
02/20/2003WO2002079183A8 Halogenated rhodamine derivatives and applications thereof
02/20/2003WO2002074742A3 Cdk-inhibitory indirubin derivatives having an increased solubility
02/20/2003WO2002074246A3 Method and compositions for optimizing blood and tissue stability of camptothecin and other albumin-binding therapeutic compounds
02/20/2003WO2002074156A3 Compositions and methods for the therapy and diagnosis of colon cancer
02/20/2003WO2002070016A8 Catecholate beta-lactam conjugates, method for producing the same and the use thereof
02/20/2003WO2002065979A3 (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes
02/20/2003WO2002062298A3 Pro-apoptotic bacterial vaccines to enhance cellular immune responses
02/20/2003WO2002056906A3 Use of mycobacterium w for the treatment of human immunodeficiency virus (hiv) disease infection
02/20/2003WO2002051427A8 Improved and stable extract from hypericum perforatum l., method for the production thereof and its use as a topical medicament
02/20/2003WO2002049993A3 High affinity small molecule c5a receptor modulators
02/20/2003WO2002047730A8 Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins
02/20/2003WO2002033376A3 Polypeptides inhibiting hepatitis c virus internal ribosome entry site (ires), and method for screening said polypeptides
02/20/2003WO2002030882A9 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
02/20/2003WO2002030860A9 Ketone compounds and compositions for cholesterol management and related uses
02/20/2003WO2002028428A3 Vaccine composition
02/20/2003WO2002026950A3 Transferases
02/20/2003WO2002015940A3 Solution of an oxazolidinone antibiotic drug
02/20/2003US20030036568 Permeation enhancers
02/20/2003US20030036552 Novel compounds
02/20/2003US20030036543 Especially as inhibitors of Aurora-2 and GSK-3, for treating diseases such as cancer, diabetes and Alzheimer's disease.
02/20/2003US20030036541 Alkylidene or dialkylidene cephalosporin-type derivatives
02/20/2003US20030036528 Administering a beta-L-(2'-azido)-2',3'-dideoxy-5-fluorocytosine
02/20/2003US20030036501 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
02/20/2003US20030036110 Isolation of viral envelope proteins; obtain cells transform with vector containing viral protein, propagate cell, lyse cells, recover envelope proteins
02/20/2003US20030035847 Acid mixture; anticancer, antitumor agents
02/20/2003US20030035811 Method of inactivating microorganisms
02/20/2003US20030035799 Glycosylated antibody
02/20/2003US20030035798 Prevention infections; such as colds, influenza
02/20/2003US20030035793 Novel immune response targeting molecules
02/20/2003US20030035792 Recombinant MVA virus, and the use thereof
02/20/2003US20030035787 Polyanhydrides with biologically active degradation products
02/20/2003CA2607992A1 Bicyclic compound, production and use thereof
02/20/2003CA2462200A1 Peptidomimetics of biologically active metallopeptides
02/20/2003CA2456928A1 Cellular virus receptors and methods of use
02/20/2003CA2456802A1 Composite superimmunogen for bi-functional vaccine use for the treatment of illnesses associated with a stromal tissue disorder
02/20/2003CA2456761A1 Novel depsipeptides and process for preparing same
02/20/2003CA2456533A1 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs
02/20/2003CA2456328A1 Complexes of a short cpg-containing oligonucleotide bound to the surface of a solid phase microcarrier and methods for use thereof
02/20/2003CA2456291A1 Hydroxamic acid derivatives
02/20/2003CA2456103A1 Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid derivatives
02/20/2003CA2455759A1 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
02/20/2003CA2455631A1 Aminoisoxazole derivatives active as kinase inhibitors
02/20/2003CA2455391A1 Nutritional supplements and methods of using same
02/20/2003CA2455027A1 In vitro assays for inhibitors of hiv capsid conformational changes and for hiv capsid formation
02/20/2003CA2454417A1 Novel benzo-fused heterocycles as endothelin antagonists
02/20/2003CA2453995A1 Tacis and br3 polypeptides and uses thereof
02/20/2003CA2453884A1 Micronutrient phosphates as dietary and health supplements
02/20/2003CA2453433A1 Methods of use for novel sulfur containing organic nitrate compounds
02/20/2003CA2451919A1 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
02/20/2003CA2451691A1 Use of r-nsaid compounds for anti-hiv treatment
02/19/2003WO2002016574A2 Method for identifying peptides that can be specifically cleaved and the use of peptide sequences of this type
02/19/2003EP1284267A1 Triazole compounds having amide linkage
02/19/2003EP1284265A1 Benzothiophene derivatives and medicinal use thereof
02/19/2003EP1284142A1 Pharmaceutical composition for treatment of infective immunologic disorders
02/19/2003EP1284140A2 Use of ritonavir (ABT-538) for improving the pharmacokinetics of drugs metabolized by cytochrome P450 in a method of treating aids
02/19/2003EP1283903A1 Drug screening systems and assays
02/19/2003EP1283887A1 Chimeric arterivirus-like particles
02/19/2003EP1283886A2 Intracellular signaling proteins
02/19/2003EP1283882A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
02/19/2003EP1283880A1 Antiviral antisense therapy
02/19/2003EP1283874A2 Novel deoxynucleoside kinase enzyme variants
02/19/2003EP1283851A2 Use of interleukin-4 antagonists and compositions thereof
02/19/2003EP1283848A2 Protein complexes and assays for screening anti-cancer agents
02/19/2003EP1283835A2 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators
02/19/2003EP1283834A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
02/19/2003EP1283833A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
02/19/2003EP1283832A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
1 ... 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 ... 1798